Nike Names Pfizer CFO David Denton as Successor to Matthew Friend
Event summary
- David M. Denton will replace Matthew Friend as Nike’s CFO on August 17, 2026.
- Friend will remain until September 4 to ensure a smooth transition.
- Denton joins from Pfizer, where he has been CFO since May 2022.
- Nike expects fourth-quarter results to align with prior guidance, excluding tariff refunds.
The big picture
Nike’s CFO transition comes as the company shifts from foundational actions to sustained growth under its Sport Offense operating model. Denton’s appointment reflects a strategic pivot toward disciplined financial management, aligning with broader industry trends where consumer brands prioritize operational efficiency amid economic uncertainty.
What we're watching
- Strategic Execution
- How Denton’s public-company experience will shape Nike’s capital allocation and long-term value creation.
- Governance Dynamics
- Whether Denton’s board experience with companies like Haleon and Tapestry influences Nike’s governance approach.
- Financial Discipline
- The pace at which Denton implements financial rigor, given his background in large-scale transformations at Pfizer and Lowe’s.
Related topics